Nima Rezaei

Targets

• LAG-3 1
• PARP 1
• TIGIT 1
• TIM-3 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers.

  Cancer medicine, Oct 2026

• Publication

  Major Depressive Disorder Signatures: A Review of Artificial Intelligence (AI)-Powered Insights Into Gut Dysbiosis.

  Health science reports, Sept 2026

• Publication

  Senescence-associated mitochondrial dysfunction as a therapeutic target in ovarian cancer: Challenges and opportunities.

  European journal of pharmacology, Aug 2026

• Publication

  Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

  The Journal of experimental medicine, Jul 2026

• Publication

  DNA methylation in glioblastoma: insights from single-cell epigenomics.

  Epigenomics, Jun 2026

• Publication

  GPR15-guided CD8+ T regulatory cells control intestinal inflammation.

  Nature, Jun 2026

• Publication

  The Silent Link: Exploring the Impact of Periodontal Diseases on Head and Neck Carcinogenesis.

  Clinical and experimental dental research, Jun 2026

• Publication

  Extracellular RNAs in pancreatic cancer: from pathogenesis to precision medicine.

  Expert opinion on biological therapy, Mar 2026

• Publication

  Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A Systematic Review.

  Cancer medicine, Feb 2026

• Publication

  Targeting T cell exhaustion in colorectal cancer: emerging roles of LAG-3, TIM-3, and TIGIT signaling in overcoming immunotherapy resistance.

  Cell communication and signaling : CCS, Jan 2026

• Publication

  Impact of Oral Immunity on Neuroinflammation and Neurodegenerative Diseases.

  Advances in experimental medicine and biology, Jan 2026

• Publication

  Oral and Craniofacial Development and Immunology.

  Advances in experimental medicine and biology, Jan 2026

• Publication

  Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.

  Advances in experimental medicine and biology, Jan 2026

• Publication

  Advances in nanomedicine-based retinal drug delivery: mechanisms and translational applications.

  Journal of nanobiotechnology, Dec 2025

• Publication

  Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis.

  Expert review of anticancer therapy, Nov 2025

• Publication

  Microcargos with Megaeffects: A Literature Review of Immunomodulatory, Diagnostic, Prognostic, and Therapeutic Dimensions of Exosomal MicroRNAs in Glioblastoma Multiforme.

  Cellular and molecular neurobiology, Nov 2025

Affiliations

• Tehran University of Medical Sciences

Co-authors

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.